• Search
  • Helpdesk
  • Sales contact
Get your demo
☰

Kayentis spirit

Kayentis enlists experts in oncology, neurodegenerative and metabolic disorders to form scientific advisory board

Board’s specialties in rare diseases, oncology, neurosciences, cardiology and metabolic disorders drive Kayentis’ expertise further in aiding pharma and biotech companies to define and implement Patient-Reported Outcomes (PROs) and electronic...

The client’s voice: why they consistently choose Kayentis

Project management
At Kayentis, client satisfaction isn't just a goal—it's our standard. We pride ourselves on delivering services that embody responsiveness, reliability,...

Why you should join Kayentis

CSR
At Kayentis, we value each individual and we form a community that goes beyond the sum of individuals. Our company’s...

Kayentis 2023 Gender Equality Index

CSR
In accordance with the provisions of the French "Professional Future" law of September 5, 2018, Kayentis has established its Gender...

Insights from Kayentis clients: why you should choose Kayentis as your eCOA & DCT provider

Project management
Responsiveness, reliability, professionalism, friendliness... discover why 95.6% of Kayentis clients recommend Kayentis in 2023!Challenge your eCOA & DCT provider: choose...

2022 Employee satisfaction survey

98% of our employees are satisfied or very satisfied with their relationship with their colleagues and their management: discover the...

Big Pharma Case Study

Project management
Kayentis has more than twenty years of success stories with Big Pharma, and has been helping Big Pharma mitigate clinical...

2021 Employee Satisfaction Survey

Discover our 2021 employee satisfaction survey results! Strong employee satisfaction and well-being at Kayentis are key ingredients for growth, enthusiasm,...

How Kayentis reduces the CO2 emissions of your eCOA projects with its carbon neutral program

CSR
In 2020, we implemented a carbon neutral program for all our clinical trials.Our goal? To reduce project CO2 emissions without...

2021 Customer Satisfaction Survey

Project management
90.8% of our clients are likely to recommend Kayentis to a colleague or a friend. Ensure the success of your...

Paving the way towards carbon neutral eCOA trials

CSR
COVID-19 caused businesses to adopt new practices, including moving many operations online and leading to a positive impact on CO2...

2020 Employee Satisfaction Survey

CSR
Embrace our spirit! With a 19% increase in new employees in 2019, the Kayentis team spirit is still going strong!...

2020 Customer Satisfaction Survey

Project management
88.1% of our customers are likely to recommend Kayentis to a colleague or friend!Thank you to all our customers! We...

Kayentis Program for Carbon-Neutral Clinical Trials

CSR
"Through the quality of the solutions, services, and databases that we provide to sponsors and CROs, we contribute to the...

Press Release // Kayentis launches new initiatives to bolster carbon-neutral clinical trials

CSR
Carbon-neutral program takes aim at reducing CO2 emissions in clinical trials, particularly phase III, without impacting their cost, quality or...

2019 Employee Satisfaction Survey

CSR
Embrace our spirit! With a 19% increase in new employees in 2019, the Kayentis team spirit is still going strong!...

Press Release // Kayentis forges ahead on five new eCOA service projects with emerging biopharma firms in Europe and US

Kayentis sets up incoming EBPs, major contributors in biomedical innovation, as well as its existing clients, with contingency plans to...

Kayentis gives back to its community by donating to two local associations

CSR
Aware of its responsibility towards the environment, Kayentis decided to help financially two health-focused associations in Grenoble and Meylan.  The...

Inclusion and gender diversity is not a given!

CSR
This can only be the result of a balanced and robust Human Resources policy.             ...

2018 Employee Satisfaction Survey

CSR
The results are in! 2018 was marked by an increase of 35% in new employees at Kayentis. We are committed...

The benefits & practicalities of aligning the objectives of an eCOA vendor with those of the study

Project management
Any enduring business relationship between a service provider and a client is built on a thorough understanding of the client’s...

Six reasons to work at Kayentis

CSR
Here are 6 reasons to knock at our door! At Kayentis, a global eCOA provider, the quality of life at...

Waste Management Report 2018

CSR
Kayentis is committed to responsible waste management After the promotion of environmentally friendly transport - 2018 Sustainable Mobility Report - (e.g....

Implementing Kayentis Spirit in the US, a key challenge for Kayentis team

Interview with Björn Felber – Project Director, Kayentis US In June 2018, Kayentis was strengthening its presence in the US...

Sustainable Mobility Report 2018

CSR
Moving together towards a better tomorrow At Kayentis, we recognize that we all play a part in ensuring each other’s...

Support from Bpifrance & Europe

We are proud to announce that Kayentis has received support from Bpifrance & Europe for the development and industrialization of...

Kayentis, a global expert in eCOA, is strenghening its US presence

Kayentis, expert in eCOA, is stengthening its presence in the US and opening offices in Boston. Guillaume Juge, Kayentis CEO...

Infography: Employee Satisfaction Barometer 2017

CSR
Well-being at Kayentis is rated 8/10! We are proud to publish the good results of our 2017 employee satisfaction barometer:...

Joining Kayentis: Values, mission and vision

Joining Kayentis means also joining a company with its own values, a real vision and a concrete mission. Beyond being...

Accreditation by the French Ministry of Research

‘We are proud to announce that we have been accredited by the French Ministry of Research as an organisation that...
Follow us on social media
Subscribe to our newsletter
You may also like

Kayentis enlists experts in oncology, neurodegenerative and metabolic disorders to...

The unquestionable value of electronic Clinical Outcome Assessments (eCOA) in...

Breaking barriers in pediatric clinical trials: perspectives from two expert...

Ensure successful outcomes with strong patient collaboration at every stage...

Empowering healing: The impact of patient partnerships in clinical trials

Collecting PRO data in leukemia clinical research: the only way...

About the author
Picture of Marc Chaperon

Marc Chaperon

Estelle brings 20+ years of experience in pre-clinical and clinical research from Top 5 Pharma and Biotech firms. Leading projects across Phases 1 to 4 in diverse therapeutic areas, she offers deep insights into clinical science, operations, and regulatory intricacies. Appointed as Chief Medical Officer at Kayentis in May 2019.

Kayentis Europe
19 bis, chemin du vieux Chêne
38240 Meylan
France
Phone: +33 (0)4 76 00 54 20

Kayentis US
186 South Street
Suite 600
Boston, Massachusetts 02111
USA